Embla Medical hf (OSSFF) Stock Statistics & Valuation Metrics

Embla Medical hf has a market cap or net worth of $1.82B. The enterprise value is $14.29B.

Market Cap

$1.82B

Enterprise Value

$14.29B

Embla Medical hf has 428,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

428,000,000

Owned by Insiders

―

Owned by Institutions

<0.01%

Embla Medical hf’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

11.34K

Employee Count

4,500

Asset Turnover

―

Inventory Turnover

―

The current PE Ratio of Embla Medical hf is 18.84. Embla Medical hf’s PEG ratio is 0.85.

PE Ratio

18.84

PS Ratio

1.78

PB Ratio

1.91

Price to FCF

15.04

Price to Operating Cash Flow

12.82

PEG Ratio

0.85

In the last 12 months, Embla Medical hf had revenue of ― and earned 51.03M in profits. Earnings per share was ―.

Revenue

―

Gross Profit

328.44M

Operating Income

72.02M

Pretax Income

―

Net Income

51.03M

EBITDA

92.84M

Earnings Per Share (EPS)

―

Operating Cash Flow

138.32M

Free Cash Flow

117.92M

Free Cash Flow per Share

0.28

Embla Medical hf pays an annual dividend of $0.02, resulting in a dividend yield of ―

Dividend Per Share

$0.02

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

6.65%

Earnings Yield

5.31%

Beta

0.50

52-Week Price Change

-21.08%

50-Day Moving Average

4.16

200-Day Moving Average

4.29

Relative Strength Index (RSI)

61.85

Average Volume (3m)

200

Embla Medical hf upcoming earnings date is Feb 02, 2027, Before Open (Not Confirmed).

Last Earnings Date

Oct 20, 2026

Next Earnings Date

Feb 02, 2027

Ex-Dividend Date

Mar 13, 2020

Embla Medical hf EV to EBITDA ratio is 10.81, with an EV/FCF ratio of 18.49.

EV to Sales

2.19

EV to EBITDA

10.81

EV to Free Cash Flow

18.49

EV to Operating Cash Flow

15.76

Embla Medical hf has ― in cash and marketable securities with $439.43M in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

$439.43M

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

Gross margin is 59.14%, with operating margin of 14.03%, and net profit margin of 9.46%.

Gross Margin

59.14%

Operating Margin

14.03%

Pretax Margin

12.67%

Net Profit Margin

9.46%

EBITDA Margin

20.26%

EBIT Margin

13.88%

The average price target for Embla Medical hf is $5.22, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target

$5.22

Price Target Upside

25.08% Upside

Analyst Consensus

Moderate Buy

Analyst Count

1

Revenue Growth Forecast

11.20%

EPS Growth Forecast

22.17%